プレスリリース | algal bio

2024/10/01Press Release: At the Innovation Field Kashiwanoha, where many IT companies gather, we conducted a demonstration experiment on the effects of our algae supplement ‘Moneru’ on improving sleep and work performance.
Feel free to contact us through our CONTACT page if you are considering health management for your company.
2024/09/25Press Release: 【Algae Supplement Moneru】 We exhibited a booth at the International Symposium on Nutritional Medicine 2024 held on September 15-16, 2024, and introduced Moneru to medical and healthcare professionals. For details, please see the press release.
2024/04/30Press Release: We have been selected for the 2024 APAC Cleantech 25, sponsored by the Cleantech Group!　For more information, please see the press release.
2023/11/08Press Release: Our “Marine Microalgae Culture Model” has been selected as an advanced project for the Tokyo Bay eSG Project in FY2023 by the Tokyo Metropolitan Government! For details, please see the linked press release.
2023/10/16Press Release: We have been selected to participate in the Indonesia-Singapore course of “J-StarX,” an entrepreneurship development and overseas dispatch program of the Ministry of Economy, Trade and Industry (METI)! For details, please see the press release.
2023/09/25Press Release: We have been selected for Berkeley SKYDECK, a world-class startup accelerator program. For details, please see the press release linked below.
2022/12/28Press Release: We have signed a capital and business alliance agreement with TAIYO NIPPON SANSO CO. For details, please refer to the press release at this link.
2022/12/28Press Release: The new 350 million yen raised in the 2nd Closing of the Series B financing brings the total amount of this Series B financing to 940 million yen and the cumulative amount raised to approximately 1.4 billion yen. For details, please refer to the press release at this link.
2022/12/26Press Release: We will exhibit at CES2023 (Japan Pavilion @Eureka Park), the world’s largest tech trade show, to be held in Las Vegas from January 5th to January 8th, 2023. Besides, our first own product “Moneru”, a supplement derived from microalgae, won a CES 2023 Innovation Award. We are very excited to introduce this innovative product at CES 2023!
2022/07/26Press Release: Algal Bio is proud to announce that we have successfully raised 590 Million JPY (ca 4.3 Million USD) in our 1st Closing of Series B financing round. Algal Bio, a leading Japanese micro-algae start-up, provides the world’s first “algae bio-foundry platform” with an intensive algae strain library multiplied with diverse screening and cultivating technologies for applying algae in all industries and applications. We believe that our technologies could be a potential solution for health, food and environment industries. With the funds raised this time, we will not only consolidate our algae bio-foundry platform, but also expedite the commercialization of algae-derived products and solutions together with our partner companies, and accelerate overseas expansion.